Will Vascepa Train Roll Past Negative Omega-3 Results?

(MedPage Today) -- The story of icosapent ethyl (Vascepa) was complicated by recent negative data, but it might be too late to expect clinicians to put a hold on their prescribing while they wait for a more definitive trial that may never happen...